ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Volume 1762, Issue 4, April 2006, Pages 453-459
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (236 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
Special issue
View Record in Scopus
 
doi:10.1016/j.bbadis.2006.01.005    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier B.V. All rights reserved.

The lack of effect of glucosamine sulphate on aggrecan mRNA expression and 35S-sulphate incorporation in bovine primary chondrocytes

Cheng-Juan Qu, Hannu M. Karjalainen, Heikki J. Helminen and Mikko J. LammiCorresponding Author Contact Information, E-mail The Corresponding Author

Department of Anatomy, Institute of Biomedicine, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland

Received 9 September 2005; 
revised 17 January 2006; 
accepted 20 January 2006. 
Available online 10 February 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Glucosamine and glucosamine sulphate have been promoted as a disease-modifying agent to improve the clinical symptoms of osteoarthritis. The precise mechanism of the action of the suggested positive effect of glucosamine or glucosamine sulphate on cartilage proteoglycans is not known, since the level of glucosamine in plasma remains very low after oral administration of glucosamine sulphate. We examined whether exogenous hexosamines or their sulphated forms would increase steady-state levels of aggrecan and hyaluronan synthase (HAS) or glycosaminoglycan synthesis using Northern blot and 35S-sulphate incorporation analyses. Total RNA was extracted from bovine primary chondrocytes which were cultured either in 1 mM concentration of glucosamine, galactosamine, mannosamine, glucosamine 3-sulphate, glucosamine 6-sulphate or galactosamine 6-sulphate for 0, 4, 8 and 24 h, or in three different concentrations (control, 100 μM and 1 mM) of glucosamine sulphate salt or glucose for 24 or 72 h. Northern blot assay showed that neither hexosamines nor glucosamine sulphate salt stimulated aggrecan and HAS-2 mRNA expression. Glycosaminoglycan synthesis remained at a control level in the treated cultures, with the exception of mannosamine which inhibited 35S-sulphate incorporation in low-glucose DMEM treatment. In our culture conditions, hexosamines or their sulphated forms did not increase aggrecan expression or 35S-sulphate incorporation.

Keywords: Osteoarthritis; Glucosamine sulphate; Bovine; Proteoglycan

Article Outline

1. Introduction
2. Materials and methods
2.1. Materials
2.2. Cell cultures
2.3. Treatment of chondrocyte cultures with different sugars
2.4. RNA extraction and Northern blot analysis
2.5. 35S-Sulphate incorporation analysis
2.6. Statistical analysis
3. Results
3.1. Effects of different forms of sulphated and non-sulphated hexosamines on aggrecan expression
3.2. Effects of glucosamine sulphate and glucose on glycosaminoglycan synthesis
3.3. Effects of glucosamine sulphate salt and glucose on aggrecan and HAS mRNA expression
4. Discussion
Acknowledgements
References




 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.